Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study

Key Points

• This study aims to quantify the relative health impact of Gavi, the Vaccine Alliance's portfolio across various subregions in 117 countries.
• Modeling approach applied to evaluate health outcomes
• Data analyzed at subregional level across 117 countries
• Comparison of health impact metrics across different vaccines and regions.
• Significant variation in health impact observed across subregions
• Certain vaccines showed greater effectiveness in specific countries
• Findings highlight the importance of targeted vaccine deployment strategies.